Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01857830 · ClinicalTrials.gov registry record · NA

The Relaxation vs. Retreat Study

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
96
Enrollment target

NCT01857830: Completed NA study, sponsored by University of California, San Francisco.

NCT01857830 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 96 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01857830, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
96 participants
Enrollment target

Study Summary

The purpose of this research study is to examine whether a short term meditation intervention can improve health, mood, and biological markers of cellular stress and aging in novice and experienced meditators compared to controls.

Primary Outcome

Participants blood will be drawn by licensed phlebotomist on the day after their arrival at La Costa Resort at their baseline assessment and again 96 hours later at their follow-up assessment. Telomerase will be measured at both time points.

Interventions

  • BEHAVIORAL Meditation Retreat
  • BEHAVIORAL Active Comparator Relaxation Group

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2013-04
Est. Completion 2013-07
Phase NA

What the finished NCT01857830 record still lists

NCT01857830 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which Meditation Retreat is the first listed.

NCT01857830 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01857830 about?

NCT01857830 is a clinical study titled "The Relaxation vs. Retreat Study". The purpose of this research study is to examine whether a short term meditation intervention can improve health, mood, and biological markers of cellular stress and aging in novice and experienced meditators compared to controls.

What is the current status of trial NCT01857830?

This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2013-04. Estimated completion is 2013-07.

What interventions are being tested in trial NCT01857830?

The interventions under investigation include: Meditation Retreat (BEHAVIORAL), Active Comparator Relaxation Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT01857830?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01857830's enrollment target sits among peer trials

96 925th of 2000 higher than 1,070 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03401762 · 96 participants · NA

    Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke

  • NCT03471260 · 96 participants · Phase 1

    Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

  • NCT03549559 · 96 participants · NA

    Imaging Histone Deacetylase in the Heart

  • NCT03841058 · 96 participants · Phase 2

    Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01857830, the US trial registry maintained by the National Library of Medicine. NCT01857830 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.